• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar).内脏利什曼病(黑热病)导致急性肾损伤的危险因素。
Am J Trop Med Hyg. 2010 Mar;82(3):449-53. doi: 10.4269/ajtmh.2010.09-0571.
2
Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.巴西阿拉戈斯州马塞约市一家热带病医院中,用葡甲胺锑酸盐治疗内脏利什曼病患者的历史系列病例。
Rev Inst Med Trop Sao Paulo. 2015 Jan-Feb;57(1):33-8. doi: 10.1590/S0036-46652015000100005.
3
Treatment of kala-azar in India.印度黑热病的治疗。
Natl Med J India. 1992 Sep-Oct;5(5):203-5.
4
Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.意大利西西里岛西部的儿童内脏利什曼病:111例回顾性分析
Eur J Clin Microbiol Infect Dis. 2002 Apr;21(4):277-82. doi: 10.1007/s10096-002-0707-3. Epub 2002 Apr 13.
5
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.两性霉素B脂质复合物与葡甲胺锑酸盐治疗HIV感染患者内脏利什曼病的随机对照试验研究
J Antimicrob Chemother. 2003 Sep;52(3):464-8. doi: 10.1093/jac/dkg356. Epub 2003 Jul 29.
6
Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine.在用两性霉素B和米替福新治疗内脏利什曼病后出现的黑热病后皮肤利什曼病(PKDL)。
Ann Trop Med Parasitol. 2009 Dec;103(8):727-30. doi: 10.1179/000349809X12554106963438.
7
[Treatment of visceral leishmaniasis or kala-azar (author's transl)].内脏利什曼病或黑热病的治疗(作者译)
Med Trop (Mars). 1978 Jul-Aug;38(4):401-4.
8
Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil.两性霉素B脱氧胆酸盐与葡甲胺锑酸盐治疗儿童内脏利什曼病的疗效和安全性:巴西一项开放标签、随机对照试验。
Rev Soc Bras Med Trop. 2017 Jan-Feb;50(1):67-74. doi: 10.1590/0037-8682-0455-2016.
9
Recent advances in the treatment of visceral leishmaniasis.内脏利什曼病治疗的最新进展
Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):130-1, 141. doi: 10.1016/0035-9203(93)90457-2.
10
Sodium antimony gluconate, amphotericin, and myocardial damage.葡萄糖酸锑钠、两性霉素与心肌损伤。
Lancet. 1998 Jun 27;351(9120):1928-9. doi: 10.1016/s0140-6736(05)78612-8.

引用本文的文献

1
Fatal Outcome of Membranoproliferative Glomerulonephritis in a Patient With Hidden Visceral Leishmaniasis.隐匿性内脏利什曼病患者发生膜增生性肾小球肾炎的致命结局
Case Rep Infect Dis. 2025 May 19;2025:3448351. doi: 10.1155/crdi/3448351. eCollection 2025.
2
A link between circulating immune complexes and acute kidney injury in human visceral leishmaniasis.循环免疫复合物与人类内脏利什曼病急性肾损伤之间的联系。
Sci Rep. 2024 Apr 30;14(1):9870. doi: 10.1038/s41598-024-60209-0.
3
From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis.从感染到死亡:内脏利什曼病发病机制概述
Pathogens. 2023 Jul 24;12(7):969. doi: 10.3390/pathogens12070969.
4
Evaluation of Renal Function Profile in Human Visceral Leishmaniasis (Kala-Azar) Patients: A Case of Western Tigray, Ethiopia.埃塞俄比亚提格雷西部人体内脏利什曼病(黑热病)患者的肾功能评估:病例分析
Res Rep Trop Med. 2023 Jun 28;14:21-33. doi: 10.2147/RRTM.S410137. eCollection 2023.
5
Updated diagnosis and graft involvement for visceral leishmaniasis in kidney transplant recipients: a case report and literature review.更新肾移植受者内脏利什曼病的诊断和移植物受累:病例报告及文献复习。
Infection. 2023 Apr;51(2):507-518. doi: 10.1007/s15010-022-01943-3. Epub 2022 Nov 3.
6
Kidney complications of parasitic diseases.寄生虫病的肾脏并发症。
Nat Rev Nephrol. 2022 Jun;18(6):396-406. doi: 10.1038/s41581-022-00558-z. Epub 2022 Mar 28.
7
Acute kidney injury in patients with Visceral Leishmaniasis in Northwest Ethiopia.埃塞俄比亚西北部内脏利什曼病患者的急性肾损伤。
PLoS One. 2021 Jun 8;16(6):e0252419. doi: 10.1371/journal.pone.0252419. eCollection 2021.
8
Urine-Based Molecular Diagnostic Tests for Leishmaniasis Infection in Human and Canine Populations: A Meta-Analysis.基于尿液的人类和犬类群体利什曼病感染分子诊断测试:一项荟萃分析。
Pathogens. 2021 Feb 27;10(3):269. doi: 10.3390/pathogens10030269.
9
Evaluation of In vitro and In vivo Protective Efficacy of Bauhinia variegata Against Leishmania donovani in Murine Model.评价猪腰豆(Bauhinia variegata)对感染利什曼原虫(Leishmania donovani)的实验鼠的体外和体内保护效果。
Acta Parasitol. 2021 Sep;66(3):812-826. doi: 10.1007/s11686-020-00326-8. Epub 2021 Feb 2.
10
Kidney biomarkers in tropical infections: an update.热带感染相关的肾脏生物标志物:研究进展。
Pathog Glob Health. 2020 Sep;114(6):302-308. doi: 10.1080/20477724.2020.1799605. Epub 2020 Jul 29.

本文引用的文献

1
Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil.葡甲胺锑酸盐治疗内脏利什曼病的严重不良反应:巴西西南部13例报告
Trop Doct. 2009 Jul;39(3):180-2. doi: 10.1258/td.2008.080369.
2
Renal tubular dysfunction in human visceral leishmaniasis (Kala-azar).人类内脏利什曼病(黑热病)中的肾小管功能障碍。
Clin Nephrol. 2009 May;71(5):492-500. doi: 10.5414/cnp71492.
3
Clinical presentation and renal evaluation of human visceral leishmaniasis (kala-azar): a retrospective study of 57 patients in Brazil.人类内脏利什曼病(黑热病)的临床表现及肾脏评估:巴西57例患者的回顾性研究
Braz J Infect Dis. 2008 Aug;12(4):329-32. doi: 10.1590/s1413-86702008000400015.
4
Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B.婴儿利什曼原虫引起的内脏利什曼病所致急性肾衰竭经单次高剂量脂质体两性霉素B成功治愈。
J Travel Med. 2008 Sep-Oct;15(5):358-60. doi: 10.1111/j.1708-8305.2008.00220.x.
5
The epidemiology of severe acute kidney injury: from BEST to PICARD, in acute kidney injury: new concepts.严重急性肾损伤的流行病学:从BEST到PICARD,见于《急性肾损伤:新概念》
Nephron Clin Pract. 2008;109(4):c188-91. doi: 10.1159/000142927. Epub 2008 Sep 18.
6
The RIFLE criteria and mortality in acute kidney injury: A systematic review.急性肾损伤的RIFLE标准与死亡率:一项系统评价
Kidney Int. 2008 Mar;73(5):538-46. doi: 10.1038/sj.ki.5002743. Epub 2007 Dec 26.
7
Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil.人类内脏利什曼病(黑热病)肾功能评估:对50名来自巴西的患者进行的前瞻性研究。
J Nephrol. 2007 Jul-Aug;20(4):430-6.
8
Amphotericin B nephrotoxicity.两性霉素B肾毒性
Saudi J Kidney Dis Transpl. 2002 October-December;13(4):481-91.
9
A review of leishmaniasis in west Africa.西非利什曼病综述
Ghana Med J. 2005 Sep;39(3):94-7.
10
[Secondary amyloidosis with irreversible acute renal failure caused by visceral leishmaniasis in a patient with AIDS].[艾滋病患者因内脏利什曼病导致继发性淀粉样变性伴不可逆性急性肾衰竭]
Nefrologia. 2006;26(6):745-6.

内脏利什曼病(黑热病)导致急性肾损伤的危险因素。

Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar).

机构信息

Department of Internal Medicine, School of Medicine, Federal University of Ceará, Ceará, Brazil.

出版信息

Am J Trop Med Hyg. 2010 Mar;82(3):449-53. doi: 10.4269/ajtmh.2010.09-0571.

DOI:10.4269/ajtmh.2010.09-0571
PMID:20207871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2829907/
Abstract

The aim of this study was to investigate the factors associated with acute kidney injury (AKI) in patients with visceral leishmaniasis (VL). The study patients had a diagnosis of VL and were admitted to a tertiary hospital. A multivariate analysis was performed to analyze the risk factors for AKI. A total of 224 patients were included. The mean age was 36 +/- 15 years. AKI was observed in 33.9% of cases. Risk factors associated with AKI were male gender (odds ratio [OR] = 2.2; P = 0.03), advanced age (OR = 1.05; P < 0.001), and jaundice (OR = 2.9; P = 0.002). There was an association between amphotericin B use and AKI (OR = 18.4; P < 0.0001), whereas glucantime use was associated with lower incidence of AKI compared with amphotericin B use (OR = 0.05; P < 0.0001). Mortality was 13.3%, and it was higher in AKI patients (30.2%). Therefore, factors associated with AKI were male gender, advanced age, and jaundice. Amphotericin B was an important cause of AKI in VL.

摘要

本研究旨在探讨内脏利什曼病(VL)患者急性肾损伤(AKI)的相关因素。研究对象为在三级医院就诊并确诊为 VL 的患者。采用多变量分析方法分析 AKI 的危险因素。共纳入 224 例患者,平均年龄为 36 +/- 15 岁。33.9%的病例发生 AKI。AKI 的相关危险因素为男性(比值比[OR] = 2.2;P = 0.03)、高龄(OR = 1.05;P < 0.001)和黄疸(OR = 2.9;P = 0.002)。两性霉素 B 与 AKI 相关(OR = 18.4;P < 0.0001),而与两性霉素 B 相比,葡萄糖酸锑钠的使用与 AKI 发生率较低相关(OR = 0.05;P < 0.0001)。死亡率为 13.3%,AKI 患者的死亡率更高(30.2%)。因此,与 AKI 相关的因素为男性、高龄和黄疸。两性霉素 B 是 VL 中 AKI 的一个重要原因。